| Ed Marie Sibal-gomez, MD | |
|
2615 Chester Ave, Bakersfield, CA 93301 | |
| (661) 869-6227 | |
| Not Available |
| Full Name | Ed Marie Sibal-gomez |
|---|---|
| Gender | Female |
| Speciality | Internal Medicine |
| Experience | 11 Years |
| Location | 2615 Chester Ave, Bakersfield, California |
| Accepts Medicare Assignments | Yes. She accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
| Identifier | Type | State | Issuer |
|---|---|---|---|
| 1639522477 | NPI | - | NPPES |
| Taxonomy | Type | License (State) | Status |
|---|---|---|---|
| 208M00000X | Hospitalist | A158231 (California) | Secondary |
| 207R00000X | Internal Medicine | A158231 (California) | Primary |
| Facility Name | Location | Facility Type |
|---|---|---|
| Adventist Health Bakersfield | Bakersfield, CA | Hospital |
| Adventist Health Tehachapi Valley | Tehachapi, CA | Hospital |
| Adventist Health Delano | Delano, CA | Hospital |
| Ridgecrest Regional Hospital | Ridgecrest, CA | Hospital |
| Group Practice Name | Group PECOS PAC ID | No. of Members |
|---|---|---|
| Hospitalist Medicine Physicians Of California Inc | 8426062027 | 178 |
News Archive
According to a new study, patients with the early signs of Alzheimer's disease had less deterioration in the areas of the brain which control memory, if they exercised regularly.
Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened Investigational New Drug application (IND) with the United States Food and Drug Administration (US FDA). The IND is for Can-Fite's lead compound, CF101, for the treatment of patients with psoriasis. This is the third US IND for CF101, and the fourth for Can-Fite.
Identical brain mechanisms are responsible for triggering memory in both sleep and wakefulness, new research at the University of Birmingham has shown.
How might the novel coronavirus be prevented from entering a host cell in an effort to thwart infection? A team of biomedical scientists has made a discovery that points to a solution.
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced it has completed a $32 million Series C financing with new investor Clarus Ventures leading the round.
› Verified 4 days ago
| Entity Name | Hospitalist Medicine Physicians Of California Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1184663965 PECOS PAC ID: 8426062027 Enrollment ID: O20060202000956 |
News Archive
According to a new study, patients with the early signs of Alzheimer's disease had less deterioration in the areas of the brain which control memory, if they exercised regularly.
Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened Investigational New Drug application (IND) with the United States Food and Drug Administration (US FDA). The IND is for Can-Fite's lead compound, CF101, for the treatment of patients with psoriasis. This is the third US IND for CF101, and the fourth for Can-Fite.
Identical brain mechanisms are responsible for triggering memory in both sleep and wakefulness, new research at the University of Birmingham has shown.
How might the novel coronavirus be prevented from entering a host cell in an effort to thwart infection? A team of biomedical scientists has made a discovery that points to a solution.
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced it has completed a $32 million Series C financing with new investor Clarus Ventures leading the round.
› Verified 4 days ago
| Entity Name | Kansal Inc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1043510183 PECOS PAC ID: 6406089739 Enrollment ID: O20140512001295 |
News Archive
According to a new study, patients with the early signs of Alzheimer's disease had less deterioration in the areas of the brain which control memory, if they exercised regularly.
Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened Investigational New Drug application (IND) with the United States Food and Drug Administration (US FDA). The IND is for Can-Fite's lead compound, CF101, for the treatment of patients with psoriasis. This is the third US IND for CF101, and the fourth for Can-Fite.
Identical brain mechanisms are responsible for triggering memory in both sleep and wakefulness, new research at the University of Birmingham has shown.
How might the novel coronavirus be prevented from entering a host cell in an effort to thwart infection? A team of biomedical scientists has made a discovery that points to a solution.
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced it has completed a $32 million Series C financing with new investor Clarus Ventures leading the round.
› Verified 4 days ago
| Entity Name | Inpatient Specialists Of California Pc |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1952792475 PECOS PAC ID: 3476864448 Enrollment ID: O20150617000915 |
News Archive
According to a new study, patients with the early signs of Alzheimer's disease had less deterioration in the areas of the brain which control memory, if they exercised regularly.
Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened Investigational New Drug application (IND) with the United States Food and Drug Administration (US FDA). The IND is for Can-Fite's lead compound, CF101, for the treatment of patients with psoriasis. This is the third US IND for CF101, and the fourth for Can-Fite.
Identical brain mechanisms are responsible for triggering memory in both sleep and wakefulness, new research at the University of Birmingham has shown.
How might the novel coronavirus be prevented from entering a host cell in an effort to thwart infection? A team of biomedical scientists has made a discovery that points to a solution.
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced it has completed a $32 million Series C financing with new investor Clarus Ventures leading the round.
› Verified 4 days ago
| Entity Name | Hospitalist Medicine Physicians Of California - Oceanside |
|---|---|
| Entity Type | Part B Supplier - Clinic/group Practice |
| Entity Identifiers | NPI Number: 1033697669 PECOS PAC ID: 5597002139 Enrollment ID: O20190121001542 |
News Archive
According to a new study, patients with the early signs of Alzheimer's disease had less deterioration in the areas of the brain which control memory, if they exercised regularly.
Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened Investigational New Drug application (IND) with the United States Food and Drug Administration (US FDA). The IND is for Can-Fite's lead compound, CF101, for the treatment of patients with psoriasis. This is the third US IND for CF101, and the fourth for Can-Fite.
Identical brain mechanisms are responsible for triggering memory in both sleep and wakefulness, new research at the University of Birmingham has shown.
How might the novel coronavirus be prevented from entering a host cell in an effort to thwart infection? A team of biomedical scientists has made a discovery that points to a solution.
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced it has completed a $32 million Series C financing with new investor Clarus Ventures leading the round.
› Verified 4 days ago
| Mailing Address | Practice Location Address |
|---|---|
| Ed Marie Sibal-gomez, MD 2615 Chester Ave, Bakersfield, CA 93301-2014 Ph: (661) 869-6227 | Ed Marie Sibal-gomez, MD 2615 Chester Ave, Bakersfield, CA 93301 Ph: (661) 869-6227 |
News Archive
According to a new study, patients with the early signs of Alzheimer's disease had less deterioration in the areas of the brain which control memory, if they exercised regularly.
Can-Fite BioPharma Ltd, a biotechnology company traded on the Tel Aviv Stock Exchange, announced today that it has opened Investigational New Drug application (IND) with the United States Food and Drug Administration (US FDA). The IND is for Can-Fite's lead compound, CF101, for the treatment of patients with psoriasis. This is the third US IND for CF101, and the fourth for Can-Fite.
Identical brain mechanisms are responsible for triggering memory in both sleep and wakefulness, new research at the University of Birmingham has shown.
How might the novel coronavirus be prevented from entering a host cell in an effort to thwart infection? A team of biomedical scientists has made a discovery that points to a solution.
TetraLogic Pharmaceuticals, a biopharmaceutical company developing novel small molecule drugs to treat cancer, today announced it has completed a $32 million Series C financing with new investor Clarus Ventures leading the round.
› Verified 4 days ago
Marsha Cheng, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2400 Wible Rd Ste 14, Bakersfield, CA 93304 Phone: 661-835-1240 Fax: 661-835-4667 | |
Sarah Dowda, NP Internal Medicine Medicare: Medicare Enrolled Practice Location: 8327 Brimhall Rd Ste 704, Bakersfield, CA 93312 Phone: 661-829-7677 Fax: 661-679-6920 | |
Peter Alagona Jr., M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 5020 Commerce Dr, Bakersfield, CA 93309 Phone: 661-324-4100 Fax: 661-324-4600 | |
Paramvir Singh Rahal, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 9802 Stockdale Hwy, Ste 102, Bakersfield, CA 93311 Phone: 661-323-1200 Fax: 661-616-5339 | |
Harieet Singh, MD Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 2415 Niles St, Bakersfield, CA 93306 Phone: 661-631-1591 Fax: 661-631-1594 | |
Bruce G Dains, PAC Internal Medicine Medicare: Medicare Enrolled Practice Location: 2701 Chester Ave, Highgrove Medical Center, Bakersfield, CA 93301 Phone: 661-326-1600 Fax: 661-323-2307 | |
Dr. Oscar W. Rico, M.D. Internal Medicine Medicare: Not Enrolled in Medicare Practice Location: 9001 Stockdale Hwy, 28 Hc, Bakersfield, CA 93311 Phone: 661-654-2395 |